Protease biology

Pharmacy

Queen's University Belfast

School of Pharmacy

Location
Belfast, United Kingdom
Funding
See university guidance
Application deadline
See university guidance

About the project

How do tumours hijack proteases to grow, spread and evade treatment? Dr Burden's research tackles this question by exploring the fundamental biology of proteases in cancer and inflammation. Using advanced molecular and cellular approaches, her group aims to uncover druggable pathways, discover new biomarkers and develop the foundations for next-generation therapies. This work sits at the interface of basic science and drug discovery, with the ultimate goal of improving outcomes for cancer patients.

  • Dr Roberta Burden: School of Pharmacy

Contact info

  • View Academic Profile
  • r.burden@qub.ac.uk

Research Interests

Open to PhD applications in the fields of:

Make a PhD enquiry

  • Protease biology
  • Drug target validation
  • Preclinical evaluation of small molecule and biologic inhibitors
  • Cancer biology and therapeutic targeting
  • Tumour microenvironment research
  • Translational pharmacology

Public outreach & key achievements

Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells. Sereesongsaeng N, Burrows JF, Scott CJ, Brix K, Burden RE. Front Pharmacol. 2023 Nov 6;14:1271435.

Lysosomal cysteine proteases are mediators of cell death in macrophages following exposure to amorphous silica nanoparticles. Ishaq F, Sereesongsaeng N, Johnston MC, Scott CJ, Burden RE. Chem Biol Interact. 2022 Apr 1;356:109882.

Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer. Sereesongsaeng N, McDowell SH, Burrows JF, Scott CJ, Burden RE. Breast Cancer Res. 2020;22(1):139.

Procathepsin V Is Secreted in a TSH Regulated Manner from Human Thyroid Epithelial Cells and Is Accessible to an Activity-Based Probe. Al-Hashimi A, Venugopalan V, Rehders M, Sereesongsaeng N, Hein Z, Springer S, Weber E, Führer D, Bogyo MS, Scott CJ, Burden RE, Brix K. Int J Mol Sci. 2020;21(23):9140.

Significance of nuclear cathepsin V in normal thyroid epithelial and carcinoma cells. Al-Hashimi A, Venugopalan V, Sereesongsaeng N, Tedelind S, Pinzaru AM, Hein Z, Springer S, Weber E, Führer D, Scott CJ, Burden RE, Brix K. Biochim Biophys Acta Mol Cell Res. 2020;1867(12):118846.

A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer. Wilkinson RDA, Burden RE, McDowell SH, McArt DG, McQuaid S, Bingham V, Williams R, Cox ÓT, O'Connor R, McCabe N, Kennedy RD, Buckley NE, Scott CJ. J Oncol. 2019;2019:3980273.

A bioavailable cathepsin S nitrile inhibitor abrogates tumor development. Wilkinson RD, Young A, Burden RE, Williams R, Scott CJ. Mol Cancer. 2016;15:29.

Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages. Hughes CS, Colhoun LM, Bains BK, Kilgour JD, Burden RE, Burrows JF, Lavelle EC, Gilmore BF, Scott CJ. Part Fibre Toxicol. 2016;13:19.

CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent manner. Wilkinson RD, Magorrian SM, Williams R, Young A, Small DM, Scott CJ, Burden RE. Oncotarget. 2015;6(30):29725-39.

Research students

PhD Title | Assessing the Molecular Mechanisms by which Cathepsin V Promotes Breast Cancer Growth and Metastasis

Name | Lauren McCosh

Years of study | 2024 - 2027

Country | Northern Ireland

PhD Title | Elucidating the Involvement of Cathepsin V in Pathobiological Mechanisms Promoting Cancer

Name | Yingming Zhou

Years of study | 2024 - 2027

Country | China

PhD Title | Exploring the Functional and Therapeutic Significance of Cathepsin V in ER-Positive Breast Cancer

Name | Yin Sing Low

Years of study | 2025 - 2028

Country | Malaysia

PhD Title | Mechanistic Dissection of Nuclear Protease Function in Tumour Biology

Name | Jamie Cunningham

Years of study | 2026 - 2029

Country | Northern Ireland

Alumni: Where are they now

PhD Title | Characterisation of the protease Cathepsin S as a novel therapeutic target in Triple-Negative Breast Cancer.

Name | Sara McDowell

Years of study | 2018 - 2022

Country | Northern Ireland

Current position | PDRA, Future Medicines Institute/Ulster University

PhD Title | Dissecting the role of Cathepsin V in breast cancer.

Name | Naphannop Sereesongsaeng

Years of study | 2017 - 2020

Country | Thailand

Current position | Higher Scientific Officer, Institute of Cancer Research, London.

PhD Title | Evaluation of nanoparticle treatment on intracellular protease activity profiles.

Name | Fatima Ishaq

Years of study | 2015 - 2018

Country | Nigeria

Current position | Lecturer, College of Nursing Science, Nigeria.

Discover More

  • Faculty of Medicine, Health & Life Sciences
  • School of Pharmacy
  • LinkedIn profile

Research areas

Protease biologyCancer BiologyCancer biologyPharmacologyResearchBiologyCancer

Related PhD opportunities